Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,085
archived clinical trials in
Cervical Cancer

An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
A Phase 2, Single Arm, Two Period Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Endometrial Carcinoma
Status: Enrolling
Updated:  12/31/1969
Wake Forest Baptist Health
2275
mi
from 98109
Winston-Salem, NC
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
A Phase 2, Single Arm, Two Period Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Endometrial Carcinoma
Status: Enrolling
Updated: 12/31/1969
Wake Forest Baptist Health
2275
mi
from 98109
Winston-Salem, NC
Click here to add this to my saved trials
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
A Phase 2, Single Arm, Two Period Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Endometrial Carcinoma
Status: Enrolling
Updated:  12/31/1969
Oklahoma Cancer Specialists and Research Institute, LLC
1568
mi
from 98109
Tulsa, OK
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
A Phase 2, Single Arm, Two Period Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Endometrial Carcinoma
Status: Enrolling
Updated: 12/31/1969
Oklahoma Cancer Specialists and Research Institute, LLC
1568
mi
from 98109
Tulsa, OK
Click here to add this to my saved trials
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
A Phase 2, Single Arm, Two Period Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Endometrial Carcinoma
Status: Enrolling
Updated:  12/31/1969
Seattle Cancer Care Alliance / University of Washington
0
mi
from 98109
Seattle, WA
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
A Phase 2, Single Arm, Two Period Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Endometrial Carcinoma
Status: Enrolling
Updated: 12/31/1969
Seattle Cancer Care Alliance / University of Washington
0
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
A Phase 2, Single Arm, Two Period Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Endometrial Carcinoma
Status: Enrolling
Updated:  12/31/1969
Saint Alphonsus Regional Medical Center
407
mi
from 98109
Boise, ID
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
A Phase 2, Single Arm, Two Period Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Endometrial Carcinoma
Status: Enrolling
Updated: 12/31/1969
Saint Alphonsus Regional Medical Center
407
mi
from 98109
Boise, ID
Click here to add this to my saved trials
Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners
Couple-Focused ACT Intervention for Couples Coping With Cancer: A Pilot Study
Status: Enrolling
Updated:  12/31/1969
Rutgers Cancer Institute of New Jersey
2388
mi
from 98109
New Brunswick, NJ
Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners
Couple-Focused ACT Intervention for Couples Coping With Cancer: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
Rutgers Cancer Institute of New Jersey
2388
mi
from 98109
New Brunswick, NJ
Click here to add this to my saved trials
Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients
A Phase I Trial of Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Recurrent or Refractory Gynecological Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients
A Phase I Trial of Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Recurrent or Refractory Gynecological Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients
A Phase I Trial of Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Recurrent or Refractory Gynecological Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Dana-Farber Cancer Institute
2485
mi
from 98109
Boston, MA
Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients
A Phase I Trial of Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Recurrent or Refractory Gynecological Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Dana-Farber Cancer Institute
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Trial of Atezolizumab and Vigil for Advanced Gynecological Cancers (A Companion Study to CL-PTL-119)
A Randomized, Intra-patient Crossover, Safety, Biomarker and Anti-Tumor Activity Assessment of the Combination of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers
Status: Enrolling
Updated:  12/31/1969
University of South Alabama Mitchell Cancer Institute
2151
mi
from 98109
Mobile, AL
Trial of Atezolizumab and Vigil for Advanced Gynecological Cancers (A Companion Study to CL-PTL-119)
A Randomized, Intra-patient Crossover, Safety, Biomarker and Anti-Tumor Activity Assessment of the Combination of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers
Status: Enrolling
Updated: 12/31/1969
University of South Alabama Mitchell Cancer Institute
2151
mi
from 98109
Mobile, AL
Click here to add this to my saved trials
Trial of Atezolizumab and Vigil for Advanced Gynecological Cancers (A Companion Study to CL-PTL-119)
A Randomized, Intra-patient Crossover, Safety, Biomarker and Anti-Tumor Activity Assessment of the Combination of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers
Status: Enrolling
Updated:  12/31/1969
Augusta University
2300
mi
from 98109
Augusta, GA
Trial of Atezolizumab and Vigil for Advanced Gynecological Cancers (A Companion Study to CL-PTL-119)
A Randomized, Intra-patient Crossover, Safety, Biomarker and Anti-Tumor Activity Assessment of the Combination of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers
Status: Enrolling
Updated: 12/31/1969
Augusta University
2300
mi
from 98109
Augusta, GA
Click here to add this to my saved trials
Trial of Atezolizumab and Vigil for Advanced Gynecological Cancers (A Companion Study to CL-PTL-119)
A Randomized, Intra-patient Crossover, Safety, Biomarker and Anti-Tumor Activity Assessment of the Combination of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers
Status: Enrolling
Updated:  12/31/1969
Billings Clinic
668
mi
from 98109
Billings, MT
Trial of Atezolizumab and Vigil for Advanced Gynecological Cancers (A Companion Study to CL-PTL-119)
A Randomized, Intra-patient Crossover, Safety, Biomarker and Anti-Tumor Activity Assessment of the Combination of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers
Status: Enrolling
Updated: 12/31/1969
Billings Clinic
668
mi
from 98109
Billings, MT
Click here to add this to my saved trials
Trial of Atezolizumab and Vigil for Advanced Gynecological Cancers (A Companion Study to CL-PTL-119)
A Randomized, Intra-patient Crossover, Safety, Biomarker and Anti-Tumor Activity Assessment of the Combination of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers
Status: Enrolling
Updated:  12/31/1969
Dartmouth Hitchcock Medical Center/Norris Cotton Cancer Center
2392
mi
from 98109
Lebanon, NH
Trial of Atezolizumab and Vigil for Advanced Gynecological Cancers (A Companion Study to CL-PTL-119)
A Randomized, Intra-patient Crossover, Safety, Biomarker and Anti-Tumor Activity Assessment of the Combination of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers
Status: Enrolling
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center/Norris Cotton Cancer Center
2392
mi
from 98109
Lebanon, NH
Click here to add this to my saved trials
Trial of Atezolizumab and Vigil for Advanced Gynecological Cancers (A Companion Study to CL-PTL-119)
A Randomized, Intra-patient Crossover, Safety, Biomarker and Anti-Tumor Activity Assessment of the Combination of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers
Status: Enrolling
Updated:  12/31/1969
GHS Cancer Institute
2228
mi
from 98109
Greenville, SC
Trial of Atezolizumab and Vigil for Advanced Gynecological Cancers (A Companion Study to CL-PTL-119)
A Randomized, Intra-patient Crossover, Safety, Biomarker and Anti-Tumor Activity Assessment of the Combination of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers
Status: Enrolling
Updated: 12/31/1969
GHS Cancer Institute
2228
mi
from 98109
Greenville, SC
Click here to add this to my saved trials
Trial of Atezolizumab and Vigil for Advanced Gynecological Cancers (A Companion Study to CL-PTL-119)
A Randomized, Intra-patient Crossover, Safety, Biomarker and Anti-Tumor Activity Assessment of the Combination of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers
Status: Enrolling
Updated:  12/31/1969
Henry Ford Health System
1931
mi
from 98109
Detroit, MI
Trial of Atezolizumab and Vigil for Advanced Gynecological Cancers (A Companion Study to CL-PTL-119)
A Randomized, Intra-patient Crossover, Safety, Biomarker and Anti-Tumor Activity Assessment of the Combination of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers
Status: Enrolling
Updated: 12/31/1969
Henry Ford Health System
1931
mi
from 98109
Detroit, MI
Click here to add this to my saved trials
Muslim Americans Reaching for Health and Building Alliances (MARHABA): Patient Navigation Intervention to Increase Breast and Cervical Cancer Screening Among Muslim Women in New York City
Muslim Americans Reaching for Health and Building Alliances (MARHABA): Patient Navigation Intervention to Increase Breast and Cervical Cancer Screening Among Muslim Women in New York City
Status: Enrolling
Updated:  12/31/1969
New York University School of Medicine
2402
mi
from 98109
New York, NY
Muslim Americans Reaching for Health and Building Alliances (MARHABA): Patient Navigation Intervention to Increase Breast and Cervical Cancer Screening Among Muslim Women in New York City
Muslim Americans Reaching for Health and Building Alliances (MARHABA): Patient Navigation Intervention to Increase Breast and Cervical Cancer Screening Among Muslim Women in New York City
Status: Enrolling
Updated: 12/31/1969
New York University School of Medicine
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
Midwest Eye Retina Practicing at Midwest Eye Institute
1862
mi
from 98109
Indianapolis, IN
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Midwest Eye Retina Practicing at Midwest Eye Institute
1862
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
Retinal Consultants of Arizona
1112
mi
from 98109
Phoenix, AZ
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Retinal Consultants of Arizona
1112
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
Retina-Vitreous Associates Medical Group
959
mi
from 98109
Beverly Hills, CA
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Retina-Vitreous Associates Medical Group
959
mi
from 98109
Beverly Hills, CA
Click here to add this to my saved trials
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
Northern California Retina Vitreous Associates Medical Group, Inc.
709
mi
from 98109
Mountain View, CA
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Northern California Retina Vitreous Associates Medical Group, Inc.
709
mi
from 98109
Mountain View, CA
Click here to add this to my saved trials
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
Retina Group of Florida
2714
mi
from 98109
Fort Lauderdale, FL
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Retina Group of Florida
2714
mi
from 98109
Fort Lauderdale, FL
Click here to add this to my saved trials
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
Marietta Eye Clinic
2163
mi
from 98109
Marietta, GA
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Marietta Eye Clinic
2163
mi
from 98109
Marietta, GA
Click here to add this to my saved trials
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
Ophthalmic Consultants of Boston
2485
mi
from 98109
Boston, MA
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Ophthalmic Consultants of Boston
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
Texas Retina Associates
1678
mi
from 98109
Dallas, TX
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Texas Retina Associates
1678
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
Retina Consultants of Houston
1892
mi
from 98109
Houston, TX
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Houston
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
Virginia Eye Consultants
2434
mi
from 98109
Norfolk, VA
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Virginia Eye Consultants
2434
mi
from 98109
Norfolk, VA
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2151
mi
from 98109
Mobile, AL
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2151
mi
from 98109
Mobile, AL
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1116
mi
from 98109
Phoenix, AZ
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1116
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
959
mi
from 98109
Duarte, CA
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
959
mi
from 98109
Duarte, CA
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
979
mi
from 98109
Long Beach, CA
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
979
mi
from 98109
Long Beach, CA
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
984
mi
from 98109
Orange, CA
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
984
mi
from 98109
Orange, CA
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
2729
mi
from 98109
Miami, FL
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
2729
mi
from 98109
Miami, FL
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2527
mi
from 98109
Tampa, FL
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2527
mi
from 98109
Tampa, FL
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2299
mi
from 98109
Augusta, GA
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2299
mi
from 98109
Augusta, GA
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1723
mi
from 98109
Maywood, IL
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1723
mi
from 98109
Maywood, IL
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
1868
mi
from 98109
Indianapolis, IN
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
1868
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1867
mi
from 98109
Indianapolis, IN
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1867
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1557
mi
from 98109
Iowa City, IA
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1557
mi
from 98109
Iowa City, IA
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2481
mi
from 98109
Scarborough, ME
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2481
mi
from 98109
Scarborough, ME
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
2328
mi
from 98109
Baltimore, MD
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
2328
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1933
mi
from 98109
Detroit, MI
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1933
mi
from 98109
Detroit, MI
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1393
mi
from 98109
Minneapolis, MN
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1393
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
1356
mi
from 98109
Omaha, NE
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
1356
mi
from 98109
Omaha, NE
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
877
mi
from 98109
Las Vegas, NV
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
877
mi
from 98109
Las Vegas, NV
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2348
mi
from 98109
Albany, NY
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2348
mi
from 98109
Albany, NY
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
2403
mi
from 98109
Brooklyn, NY
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
2403
mi
from 98109
Brooklyn, NY
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2283
mi
from 98109
Charlotte, NC
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2283
mi
from 98109
Charlotte, NC
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2275
mi
from 98109
Winston-Salem, NC
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2275
mi
from 98109
Winston-Salem, NC
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1963
mi
from 98109
Kettering, OH
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1963
mi
from 98109
Kettering, OH
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1523
mi
from 98109
Oklahoma City, OK
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1523
mi
from 98109
Oklahoma City, OK
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2373
mi
from 98109
Philadelphia, PA
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2373
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2083
mi
from 98109
Chattanooga, TN
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2083
mi
from 98109
Chattanooga, TN
Click here to add this to my saved trials